Fresh Rounds

Contraline, Inc. funding

Contraline, Inc., a biotechnology company based in Charlottesville, VA, filed a Form D with the SEC on June 10, 2026 and reported $55.8M raised of a $116M offering.

Amount raised$55.8M
Offering size$116M
Filed with the SECJune 10, 2026
First saleMay 29, 2026
IndustryBiotechnology
SecuritiesEquity
LocationCharlottesville, VA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far77
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Virginia